These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 34775884)

  • 1. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.
    Zhou W; Wang X; Chang J; Cheng C; Miao C
    Crit Rev Clin Lab Sci; 2022 May; 59(3):203-218. PubMed ID: 34775884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA methylation: A potential therapeutic target in autoimmune disease.
    Li L; Xia X; Yang T; Sun Y; Liu X; Xu W; Lu M; Cui D; Wu Y
    Int Rev Immunol; 2024 May; 43(3):160-177. PubMed ID: 37975549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of RNA methylation in gastrointestinal cancers.
    Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
    Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases.
    Zhou W; Wang C; Chang J; Huang Y; Xue Q; Miao C; Wu P
    Front Pharmacol; 2021; 12():722728. PubMed ID: 34489709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
    Liu Y; Zhu J; Ding L
    Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives.
    Chen Y; Jiang Z; Yang Y; Zhang C; Liu H; Wan J
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126773. PubMed ID: 37690652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of RNA methylation in tumor immunity and its potential in immunotherapy.
    Li Y; Jin H; Li Q; Shi L; Mao Y; Zhao L
    Mol Cancer; 2024 Jun; 23(1):130. PubMed ID: 38902779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of RNA N6-methyladenosine Modifications in Systemic Lupus Erythematosus.
    Xia X; Qu R
    Cell Biochem Biophys; 2024 Dec; 82(4):3223-3234. PubMed ID: 39095568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the regulatory role of RNA methylation modifications in glioma.
    Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
    J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Writers, readers, and erasers RNA modifications and drug resistance in cancer.
    Chen D; Gu X; Nurzat Y; Xu L; Li X; Wu L; Jiao H; Gao P; Zhu X; Yan D; Li S; Xue C
    Mol Cancer; 2024 Aug; 23(1):178. PubMed ID: 39215288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
    Cusenza VY; Tameni A; Neri A; Frazzi R
    Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine.
    Xu Y; Zhang M; Zhang Q; Yu X; Sun Z; He Y; Guo W
    Front Cell Dev Biol; 2021; 9():767668. PubMed ID: 34917614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy.
    Liu L; Yu L; Wang Y; Zhou L; Liu Y; Pan X; Huang J
    Pharmacol Res; 2024 Sep; 207():107305. PubMed ID: 39002868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.
    Huang Y; Xue Q; Chang J; Wang Y; Cheng C; Xu S; Wang X; Miao C
    Arthritis Res Ther; 2023 Oct; 25(1):189. PubMed ID: 37784134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential regulatory role of RNA methylation in ovarian cancer.
    Zhao S; Zhang M; Zhu X; Xing J; Zhou J; Yin X
    RNA Biol; 2023 Jan; 20(1):207-218. PubMed ID: 37194218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequencing methods and functional decoding of mRNA modifications.
    Li K; Peng J; Yi C
    Fundam Res; 2023 Sep; 3(5):738-748. PubMed ID: 38933299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.
    Shi H; Chai P; Jia R; Fan X
    Mol Cancer; 2020 Apr; 19(1):78. PubMed ID: 32303268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
    Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
    Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.